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The positive-strand RNA genome of the calicivirus rabbit hemorrhagic disease virus (RHDV) contains one long open
reading frame (ORF) covering almost 95% of the genomic RNA. Translation of this ORF leads to a polyprotein that is
proteolytically processed at eight sites. Site nos. 4 and 5 from the amino-terminus are located within the protein p41 and
obviously belong to alternative cleavage pathways leading to p23/2 and p18 or p29 and p13. Seven of the eight cleavage sites
were identified before and the flanking sequences fulfill the requirements of the known RHDV protease, so that it is very likely
that all theses sites are cleaved by this enzyme. The last unknown cleavage site was no. 4, one of the two alternative sites
within p41 that separates the nonstructural proteins p23/2 and the VPg precursor p18. Mutagenesis studies identified
aspartic acid at position 936 and arginine at position 937 as the residues that flank the cleavage site. The sequence at the
processing site is unusual for the RHDV 3C-like protease since other sites display glutamic acid or glutamine at the P1 site
and glycine, aspartic acid, or threonine at the P1 site. Expression of a polyprotein fragment lacking the viral proteaseElsevier Science (USA)
INTRODUCTION
Rabbit hemorrhagic disease virus (RHDV) represents
the prototype member of the genus Lagovirus within the
family Caliciviridae which also comprises human patho-
gens classified in the genera Norwalk-like virus and
Sapporo-like virus, and a fourth genus termed Vesivirus
(Green et al., 2000). RHDV is the causative agent of a
highly contagious disease in rabbits that was first de-
scribed in China (Liu et al., 1984) and later on in many
countries worldwide (Gregg et al., 1991; Lawson, 1995;
Mitro and Krauss, 1993; Nowotny et al., 1997; Ohlinger et
al., 1990; Pennisi, 1997).
Calicivirus virions represent nonenveloped particles
that are mainly built from one protein species. The major
capsid protein spontaneously assembles into virus-like
particles in the absence of other viral components
(Geissler et al., 1999; Jiang et al., 1992; Laurent et al.,
1994; Nagesha et al., 1995; Sibilia et al., 1995). A further
minor structural protein, that for RHDV is called VP10, is
presumably found within the virion together with the
positive-strand RNA genome (Glass et al., 2000; Sosnovt-
sev and Green, 2000; Tohya et al., 1999; Wirblich et al.,
1996). The genomic RNA has a length of 7.4 to 8.3 kb and
contains a 3 poly(A) tract (Clarke and Lambden, 1997,
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3522000; Green et al., 2000). A virus-encoded protein (VPg)
is bound to the RNA (Dunham et al., 1998; Ehresmann
and Schaffer, 1977; Herbert et al., 1997; Meyers et al.,
1991a; Sosnovtsev and Green, 2000). Recently, a tyrosine
residue responsible for the covalent binding of the RHDV
VPg has been mapped (Machı´n et al., 2001). The
genomic RNA contains a long open reading frame (ORF
1) that encodes the nonstructural proteins (NSP). For
RHDV the hypothetical primary translation product has a
molecular weight of ca. 257 kDa and comprises the
major capsid protein VP60 in addition to the NSP (Mey-
ers et al., 1991b). This polyprotein gives rise to mature
viral proteins by proteolytic processing (Alonso et al.,
1996; Boniotti et al., 1994; Joubert et al., 2000; Wirblich et
al., 1995). According to our investigations, the RHDV ORF
1 polyprotein contains the proteins NH2-p16-p60-p41-
p72-VP60-COOH (Ko¨nig et al., 1998; Meyers et al., 2000;
Wirblich et al., 1996). VP60 is also expressed from a
subgenomic mRNA of about 2.4 kb that is 3 coterminal
with the genomic RNA. P60 is further cleaved into p23
and p37, a protein with similarity to picornavirus 2C that
exhibits NTPase activity (Marin et al., 2000). P72 repre-
sents a fusion protein composed of the viral cysteine
protease (Boniotti et al., 1994) and the RNA-dependent
polymerase (Va´zquez et al., 2000) and is cleaved with
rather low efficiency into p15 protease and p58 polymer-
ase. Following an apparently complex processing
scheme, p41 gives rise to products of 23 and 18 kDarevealed that the newly identified site is not cleaved by th
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(p23/2 and p18), or alternatively, to polypeptides of 29
and 13 kDa (p29 and p13). The latter product representse RHDV
VPg. Until now, no evidence was found in the transient
expression studies that p29 might be converted into
p23/2 or that p18 might be cleaved to give rise to p13. A
polypeptide of about 5 kDa that could represent the
second product of these hypothetical cleavages was not
found and first analyses of the kinetics of the polyprotein
processing did not indicate precursor/product relation-
ships for p29 and p23/2 or p18 and p13, respectively
(Meyers et al., 2000).
According to the above described genome organiza-
tion, cleavage of the ORF 1 polyprotein has to occur at
eight cleavage sites. Seven of the eight sites were iden-
tified in previous studies (Alonso et al., 1996; Joubert et
al., 2000; Meyers et al., 2000; Wirblich et al., 1995). They
all display sequences that fit with the requirements de-
termined for the RHDV 3C-like protease, an enzyme
showing significant similarity to the 3C proteases of
picornaviruses (Boniotti et al., 1994; Wirblich et al., 1995).
It is therefore very likely that these seven cleavage sites
are all processed by the known viral protease. The still
unknown site is located within p41 and separates the
processing products p23/2 and p18. With regard to the
amino-terminus of the polyprotein, this site represents
cleavage site no. 4. A candidate processing site with a
consensus sequence for the 3C-like protease was iden-
tified by sequence analysis. This site was located be-
tween positions 940 and 941 of the polyprotein and
displayed glutamine at P1 and glycine at P1. With regard
to sequence as well as location this site seemed well
suited. However, insertion of proline instead of the glu-
tamine at P1 did not block the generation of p23/2 and
p18 (Meyers et al., 2000), although such a mutation is
known to abolish cleavage by the RHDV protease (Wir-
blich et al., 1995). Using elaborate mutagenesis analyses
combined with a transient protein expression system, we
were able to localize the last missing cleavage site in the
RHDV polyprotein. Moreover, expression of a short frag-
ment of the polyprotein lacking the 3C-like protease
showed that processing at this site was not dependent
on the presence of the known RHDV protease. Thus, we
were able to show for the first time that a site in the
polyprotein of a calicivirus is cleaved by a proteolytic
activity other than the known 3C-like protease.
RESULTS
Detection of RHDV proteins after transient expression
of truncated cDNA constructs
Similar to the human caliciviruses, RHDV can so far
not be propagated in tissue culture cells. Thus, studies
on the RNA replication and gene expression of this virus
are hampered by the lack of a simple experimental sys-
tem. RHDV proteins were first identified in liver extracts
or in purified viral particles derived from infected animals
(Ohlinger et al., 1990; Parra and Prieto, 1990). Further
analyses were based on in vitro translation of viral RNA
or expression of viral sequences in prokaryotic systems
and insect cells (Alonso et al., 1996; Boga et al., 1994;
Boniotti et al., 1994; Laurent et al., 1994; Sibilia et al.,
1995; Wirblich et al., 1995, 1996). Protein analyses were
also conducted after infection of isolated rabbit primary
hepatocytes (Ko¨nig et al., 1998). Recently, we have es-
tablished a transient expression system based on the
full-length RHDV cDNA clone pR1228 that allowed anal-
ysis of polyprotein processing and identification of cleav-
age sites by site-directed mutagenesis (Meyers et al.,
2000). However, site no. 4 could not be identified during
these studies. For a quicker approach to locate this site,
a truncated version of pR1228 was generated that was
termed pR1303IX. This construct encompassed part of
the sequence coding for p37, the p41- and p15 protease-
coding region, and part of the viral polymerase gene (Fig.
1). This truncation had no qualitative effect on the pro-
cessing of p41. P23/2 and p18 were readily detected and
p29 was visible, even though it was detected only as a
faint band (Fig. 2A). VPg could also be demonstrated
when an appropriate antiserum was used (data not
shown). Apparently, the yield of the individual cleavage
products differed from what was obtained after expres-
sion of pR1228. Processing at site no. 4 seemed to occur
more efficiently after expression of pR1303IX, whereas
only very low amounts of p29 were visible.
Mapping of cleavage site no. 4 by site-directed
mutagenesis
Because of the size of the different products generated
by processing of p41, the cleavage site no. 4 should be
located within a stretch of amino acids corresponding to
about positions 930 to 950 of the ORF 1 encoded polypro-
tein. Within the respective sequence the QG dipeptide
represents the most likely processing site for the RHDV
protease but the mutation present in construct pR1228/
940 had no influence on the processing (Meyers et al.,
2000). Other sequences in this region could also repre-
sent targets for the known protease. Alternatively, the
protease could cleave the QG in the wild-type sequence
but could switch to sites with less appropriate se-
quences when the regular site was blocked. Aspartic
acid (D) can also serve as P1 residue of a cleavage site
(Wirblich et al., 1995), and the region containing the
cleavage site contains several D residues. We therefore
established a construct, in which the mutation of the Q at
position 940 was combined with several exchanges di-
rectly affecting either the D residues or putative P1
residues following aspartic acid (Table 1). Comparison of
the proteins expressed from the mutant with the multiple
changes (pR1321) with those derived from pR1303IX
showed that p23/2 and p18 were no longer detectable for
the former construct (Fig. 2B). Thus, one or several of the
mutations present in pR1321 were apparently able to
block the cleavage at site no. 4.
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FIG. 1. Schematic representation of the expression constructs used for the experiments described below. The top shows bars symbolizing the ORFs
1 and 2 in the RHDV genome together with a scale in amino acids and the location of regions with known or suggested functions (Hel: putative
helicase, 2C-like; Pro: 3C-like protease; Pol: RNA-dependent RNA polymerase). In addition, the positions of the known or proposed (indicated by “?”)
cleavage sites are given with the P1 and P1 residues and a number reflecting their positions with regard to the amino-terminus of the polyprotein.
Below, the processing scheme of the ORF 1 encoded proteins are indicated (black bars) (Meyers et al., 2000) together with the location of the fusion
proteins that were used for generation of anitsera “F”, “G”, “H”, “I”, and “J” (gray bars) (Wirblich et al., 1996). The part below the antisera shows the
regions of ORF 1 present in constructs pR1218/1382 (Meyers et al., 2000), pR1303/1321, pR1416, pR862, and pR1418 (pR1228: full-length construct;
pR1303: amino acids (aa) 702-1372; pR1416: aa 702-1108; pR862: aa 1109–1251; pR1418: aa 1109–1767). Please note that pR1382 and pR1321 represent
variants of pR1228 and pR1303, respectively, that encode the same polyprotein regions as the parental constructs, however, with a mutation at site
no. 4. The viral sequences are inserted downstream of an internal ribosomal entry site from encephalomyocarditis virus (IRES). Pol* indicates that
the polymerase-coding region is truncated at the 3-end. The position of the cleavage site no. 4 identified in the present article is marked by a broken
line.
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For further analysis, a set of mutants was established
with the individual constructs containing either one, two,
or three of the exchanges present in pR1321. The series
was organized in a way that the different mutations could
be tested alone or in combination with the Q940P muta-
tion (Table 1). Expression of the different plasmids
showed that the p23/2 and p18 bands were absent in all
cases where histidine was present at position 936 in-
stead of aspartic acid (Fig. 2B). To verify that this position
indeed was important for the processing, further con-
structs were established with D936 exchanged for G and
R937 exchanged for G or P, respectively. Transient ex-
pression studies revealed that the mutation D936G pre-
vented cleavage at site no. 4 and R937P reduced the
cleavage efficiency to almost zero. In contrast, R937G
seemed to enhance the processing as could be con-
cluded from the relation between the p41 band and the
bands representing the processing products (Fig. 2B).
To obtain additional information on cleavage site no. 4,
four mutants were established that contained cysteine
codons at positions 935, 936, 937, or 938, respectively
(plasmids pR1303-P2/Cys, pR1303-P1/Cys, pR1303-P1/
Cys, or pR1303-P2/Cys) (Fig. 3A). In these constructs the
only cysteine codon residing in the wild-type p18 coding
sequence (position 971) was exchanged for a serine
codon. Thus, p18 derived from these constructs can only
be labeled with [35S]cysteine when the cysteine codon
introduced by mutation is located downstream of cleav-
age site no. 4. Figure 3B shows the results of transient
expression and immunoprecipitation of the [35S]cysteine-
labeled proteins. As expected the mutation P1/Cys at
position no. 936 prevents cleavage at site no. 4. In con-
FIG. 2. (A) Comparison of the products expressed from the full-length construct pR1228 and the truncated product pR1303IX precipitated with
antiserum H raised against a bacterial fusion protein containing residues 875-1023 of the polyprotein (Wirblich et al., 1996). The lower part shows the
proteins separated by SDS–PAGE. Above, the region of ORF 1 covered by pR1303IX is indicated together with the products of p41 processing. VPg
(p13) is not visible on the gel because it is only poorly precipitated with antiserum H. The cells transfected with pR1303IX were labeled with
[35S]cysteine only; in consequence, p18 is visible as a weak band, since it contains only one cysteine residue. Protein p29 was detected for pR1303IX
only after prolonged exposure. (B) Analysis of the products expressed from pR1303IX or mutants thereof with changes in the region coding for amino
acids 930 to 950 of the ORF 1 encoded polyprotein. The antiserum used for precipitation is indicated on top. Above the gels, the names of the
constructs are given and below the construct itself and a processing scheme of the encoded protein is indicated. The signal intensity obtained in
the presented experiment for pR1334c is rather low so that p23/2 is hardly detectable. Longer exposure clearly proved the presence of p23/2. For
further details, see also legend to Fig. 1 and Table 1.
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trast, the mutants with changes at the proposed P2, P1,
or P2 positions of the cleavage site were processed but
with different efficiency. Most importantly, p18 was visi-
ble only after expression of pR1303-P1/Cys and pR1303-
P2/Cys. Since this processing product could be de-
tected also for the pR1303-P2/Cys mutant when [35S]me-
thionine was present in the labeling medium (not shown),
the results of these experiments provide a strong argu-
ment for the conclusion that cleavage at site no. 4 occurs
between D936 and R937.
It was observed before for site no. 3 that mutations
blocking processing at this site also prevented cleavage
at site nos. 4 and 5 (Meyers et al., 2000). Mutations at site
no. 4 were therefore also studied in the context of the
complete ORF 1 encoded polyprotein to identify their
putative influence on processing at other sites. The
cDNA sequences from plasmids pR1321 and pR1334d
were inserted into pR1228 leading to constructs pR1382a
and b with five mutations present in pR1382a and the
D936H mutation present in pR1382b. Transient expres-
sion of these plasmids resulted in the expected pattern
of processing products since p23/2 and p18 could not be
detected (Fig. 4). The mutations analyzed here had no
obvious influence on the processing at the other sites
(Fig. 4 and data not shown).
Processing at site no. 4 in the absence of the known
viral protease
The sequence at the putative cleavage site no. 4 does
not fit well with the consensus sequence determined for
the RHDV 3C-like protease before, so that it was some-
what doubtful that this site could be processed by the
known RHDV cysteine protease. We therefore conducted
expression experiments with constructs lacking the pro-
tease-coding region to see whether this enzymatic activ-
TABLE 1
Summary of the Mutations Introduced into the Region from Position 930 to 950 of the ORF1-Encoded Polyprotein
Note. First column: names of the mutant plasmids; second column: amino acid sequences corresponding to positions
930 to 950. Changes with regard to the wild-type sequence encoded by pR1303IX are marked by a box and the two
residues flanking the determined cleavage site no. 4 are highlighted. The sequences are shown in the one letter code.
Third column: summary of the results of the cleavage experiments with “” and “”, indicating that cleavage was
observed or not observed, respectively.
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ity was required for processing at this site. The substrate
constructs pR1416a and pR1416b were equivalent to
pR1303IX with regard to the 5 terminal regions but
terminated at the 3 end of the p41-coding region (Fig. 1).
For pR1416a, processing at site no. 3 is prevented by the
E718G mutation, whereas pR1416b displays the wild-type
sequence. Expression of pR1416a and pR1416b resulted
in detection of the fusion protein fp43 composed of p41
and a small carboxyl-terminal fragment of p37 (Fig. 5). In
addition, both pR1416a and pR1416b yielded bands of 18
and 25 kDa in the absence of the 3C-like protease.
To obtain more information on the different expression
products, we provided the 3C-like protease in trans.
Another two constructs were generated: plasmid pR862
encodes only the p15 protease, whereas pR1418 con-
tains the sequence coding for the protease/polymerase
fusion protein p72 that is partially processed into pro-
tease and polymerase (Fig. 5). When pR1416b was co-
expressed with one of the protease constructs, fp43 was
converted into p41, showing that site no. 3 could be
cleaved in trans regardless whether the p15 protease
was present alone or in addition to p72 and p58. We
were not able to detect p29 or VPg so that it seems likely
that site no. 5 cannot be processed in trans. As expected,
the mutation present in pR1416a prevented cleavage at
site no. 3 so that fp43 remained visible after coexpres-
sion of this construct with either of the protease-coding
plasmids. When the proteins were derived from pR1416b,
coexpression with the protease resulted in loss of fp25
and detection of a new band of 23 kDa. Again, this effect
was not visible for pR1416a with site no. 3 blocked. Thus,
fp25 represents the amino-terminal product containing
p23/2 with an amino-terminal extension composed of 17
carboxyl-terminal amino acids of p37 and 12 vector-
derived residues. This fusion protein is processed by the
p15 protease and gives rise to p23/2 and the short
amino-terminal fragment that cannot be detected with
our sera. Both the fp43 and the fp25 bands are weak
compared to the corresponding products p41 and p23/2.
This cannot be due to lower expression levels since the
FIG. 4. Analysis of the products expressed from the full-length con-
struct pR1228 (WT) or mutants thereof with changes affecting the
cleavage site no. 4. Construct pR1382a contains the same mutations as
pR1321, and in pR1382b the D codon at position 936 was changed into
a triplet coding for histidine as in pR1334d. For further details, see also
legends to Figs. 1 and 2, as well as Table 1.
FIG. 3. (A) Presentation of the amino acid sequences flanking the
putative cleavage site no. 4 in the wild-type construct pR1303IX (WT)
and the four mutants with the proposed P2, P1, P1, or P2 residues
exchanged for cysteine, respectively. The putative P1 and P1 residues
are marked by a box; the introduced cysteine residues are highlighted.
Note that the mutant constructs contain another change further down-
stream (C971S). (B) Analysis of the products expressed from the mu-
tants presented in (A). The proteins were labeled in situ with [35S]cys-
teine. The antisera used for precipitation are indicated on top (anti-
serum “G” raised against aa 704–875 and antiserum “I” raised against
aa 1023–1170 of the ORF 1 polyprotein). Above the gels, the mutations
present in the constructs are designated and below the gels, a pro-
cessing scheme is indicated. For further details, see also legends to
Figs. 1 and 2.
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p18 bands exhibit comparable intensity in all cases. It is
therefore likely that the aberrant fusion products are less
stable than the cleavage products representing the nat-
ural viral proteins. The fp25 signal in Fig. 5 is diffuse and
appears to represent a double band. We have no expla-
nation for this finding. Since, however, p18 is clearly
detected as one band and fp25 is converted to homoge-
neous p23/2 in the presence of the viral protease, the
appearance of an fp25 doublet is obviously not due to
heterogeneous processing at site no. 4. Taken together,
these data show that processing at site no. 4 occurs in
the absence of the known RHDV protease so that p18
FIG. 5. Analysis of the products obtained after expression of constructs pR1416a/b that lack the protease-coding region of ORF 1. pR1416a and
pR1416b were either expressed alone or in combination with pR862 or pR1418 that code for the viral protease. The left part shows the products derived
from the two protease constructs pR862 and pR1418 precipitated with the antisera indicated by letters below the gel. The products pp (protease/
polymerase fusion protein p72), p58 (polymerase), and Pro (p15 protease) are marked on the left side of the gel. The right part shows the products
precipitated with antiserum F after expression of the cDNA constructs pR1414a and pR1416b in the absence or presence of the protease constructs.
The transfected constructs are indicated above the gel. Below the gels the regions of ORF 1 expressed from the different constructs and the products
visible on the gels are indicated as black bars. Antiserum J was raised against a bacterial fusion protein containing residues 1173–1332 of the
polyprotein (Wirblich et al., 1996). For further details, see also legends to Figs. 1 and 2.
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can be detected in all lanes of Fig. 5 except for the
negative control.
DISCUSSION
Polyprotein processing represents a crucial step in the
gene expression of positive-strand RNA viruses since it
not only provides the appropriate amounts of mature
virus proteins but also allows regulation in coordination
with the virus lifecycle. The viruses use different kinds of
proteases to cleave their polyproteins at defined sites. In
addition to cellular enzymes such as signalases or signal
peptide peptidases a variety of viral enzymes are known
that belong to different protease clans (Babe´ and Craig,
1997; Bazan and Fletterick, 1990; Dougherty and Semler,
1993; Ryan and Flint, 1997; Strauss, 1990). The picorna-
virus 3C proteases represent the prototype members of
the enzyme family C3 that is classified within clan PA
(Barret et al., 2001). 3C-like proteases use cysteine as
active site residue but nevertheless share structural sim-
ilarities with serine proteases of the chymotrypsin type
that also belong to clan PA together with a variety of
serine proteases of positive-strand RNA viruses (Babe´
and Craig, 1997; Bazan and Fletterick, 1990; Dougherty
and Semler, 1993). Protease 3C executes most steps of
picornavirus polyprotein processing. Cleavage sites are
defined by specific sequences and probably also struc-
tural features (Kuhn and Wimmer, 1987; Palmenberg,
1987). The caliciviruses exhibit significant homology to
picornaviruses with regard to type, organization, and
function of the nonstructural proteins in the polyprotein,
and it therefore was not surprising to find out that they
also express a 3C-like protease. The proteolytic activity
was initially tentatively localized by identification of se-
quence motifs. Later on, experimental work allowed the
final mapping of the proteolytically active region in the
RHDV polyprotein (Boniotti et al., 1994). Further charac-
terization of the protease included the identification of
the active site residues and the sequences at different
cleavage sites (Alonso et al., 1996; Joubert et al., 2000;
Wirblich et al., 1995). A mutagenesis study elucidated the
sequence preferences at the cleavage site (Wirblich et
al., 1995). Recently, we located further cleavage sites by
mutagenesis experiments. The changes were introduced
at sites that were identified by screening the polyprotein
for sequences fulfilling the criteria of cleavage sites
(Meyers et al., 2000). By this and other approaches,
seven cleavage sites were identified. All these cleavage
sites fulfilled the criteria for a sequence that could be
cleaved by the known viral protease. Expression of the
ORF 1 encoded polyprotein with the protease inactivated
by site-directed mutagenesis did not indicate that any
processing occurred in the absence of the viral protease
(data not shown), so that it seemed as if all sites were
cleaved by this single protease. However, this conclu-
sion turned out to be unjustified when mutagenesis anal-
yses revealed a dominant hierarchy for processing of the
p41 region of the polyprotein. After expression of the
full-length polyprotein, internal processing of p41 at ei-
ther site no. 4 or no. 5 was only observed when cleavage
at site no. 3 was not blocked (Meyers et al., 2000). Thus,
processing at sites no. 4 or no. 5 had not necessarily to
be executed by the viral protease but would nevertheless
be prevented in polyproteins with inactivated 3C-like
protease due to the absence of processing at the “higher
order” site no. 3.
Six of the already known cleavage sites display glu-
tamic acid as P1 residue, whereas site no. 5 contains a
glutamine at this position. At the P1 position the RHDV
protease prefers glycine (five of the seven sites) but
aspartic acid and threonine are also found. The unusual
sequence of the cleavage site no. 4 with D936 and R937
as P1 and P1 residues provided the first evidence that
this site might not be processed by the known protease.
Mutagenesis studies conducted for the site no. 6 at the
amino-terminus of the protease had shown before that
aspartic acid in P1 lowered cleavage efficiency consid-
erably (Wirblich et al., 1995). The same was true for
arginine at P1, and thus it can be hypothesized that a
combination of these two changes in a DR cleavage site
should result in only very low cleavage efficiency for the
3C-like protease. Expression of a construct lacking the
sequence coding for this protease resulted in detection
of p18. The amino-terminal product derived from this
construct could be converted into p23/2 in a trans-cleav-
age experiment. This trans-cleavage reaction was au-
thentic since it could be prevented by a mutation block-
ing site no. 3. Taken together, p41 is processed in the
absence of the viral 3C-like protease and this reaction
yields polypeptides with the size of the known process-
ing products. Thus, it can be concluded that site no. 4 is
not processed by the known RHDV protease but by
another proteolytic activity.
The amino acid sequence from position 930 to 950
comprising the proposed cleavage site no. 4 is abso-
lutely conserved for a variety of sequenced RHDV iso-
lates (Accession Nos. U54983, X87607, Z29514, Z49271)
and even the sequence of the related European brown
hares syndrome virus (LeGall et al., 1996) contains only
three exchanges that do not affect the region from P6 to
P6. It therefore is likely also that the EBHSV protein is
cleaved at the identified site by a not yet identified
second protease.
Recruitment of more than one proteolytic activity for
polyprotein processing is observed in a variety of posi-
tive-strand RNA viruses. Cellular proteases can play an
important role in this process. In addition to enzymes
commonly used by enveloped viruses, such as, e.g.,
signalases or signal peptide peptidases, also rather
unique constellations have been observed, e.g. to the
use of ubiquitin-specific and similar proteases for pro-
cessing of proteins from pestiviruses with recombined
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genomes (Ku¨mmerer et al., 2000; Meyers and Thiel,
1996). Alternatively, the second protease can be encoded
by the viral genome as found for many positive-strand
RNA viruses. Picornaviruses from the genera Enterovirus
and Rhinovirus express a 2A protein that represents a
protease sharing a considerable degree of similarity with
3C (reviewed by Ryan and Flint, 1997). The 2A protease
is responsible for the primary cleavage of the polyprotein
that occurs cotranslationally before 3C has been trans-
lated and generates protein P1. Apparently, the rapid
release of P1 is essential or at least beneficial for the
viruses since cardioviruses and aphthoviruses also fol-
low this strategy. However, these latter viruses do not
express a protease similar to 2A. Instead, the carboxyl-
terminus of their 2A protein adopts an unstable confor-
mation that provokes a cotranslational break of the pep-
tide bond at the boundary of 2A and 2B (Hahn and
Palmenberg, 1996, 2001; Ryan and Drew, 1994; Ryan et
al., 1991). Based on these data, processing at site no. 4
of the RHDV polyprotein could be done by a cellular
enzyme, a second viral protease, or could result from
spontaneous hydrolysis of the peptide bond. Sequence
analyses did not give any hints for the presence of a
second protease in the RHDV polyprotein. There is no
striking homology between the region containing site no.
4 and the sequences forming the unstable peptide bond
at the boundary of 2A and 2B of cardioviruses and aph-
thoviruses, even though a motif DPVP is present in the
RHDV protein that is reminiscent of the conserved NPGP
sequence at the cleavage sites of those picornaviruses.
The DPVP is found at positions 11 to 8 upstream of the
mapped cleavage site and our analyses gave no indica-
tions for processing within this sequence. Moreover, in
vitro translation of RNA derived from pR1416 did not
result in the detection of processed proteins (data not
shown). Nevertheless, self-processing cannot be ex-
cluded on the basis of our data. The same is true for a
process involving a cellular protease but there are no
data available that support either of these hypotheses.
Further analyses are necessary to identify the mecha-
nism and the putative actor(s) responsible for the gen-
eration of p23/2 and p18.
A question of major interest is, why does processing of
the p41 region of the RHDV polyprotein follow such a
complex scheme with two alternative pathways that lead
to coexistence of at least five different polypeptides in-
cluding p41? It might of course be that part of the obser-
vations we made are influenced by the artificial transient
expression system. For FCV, processing of the capsid
protein precursor has been observed in the absence of
the FCV 3C-like protease, and it has been hypothesized
that a protease encoded by MVA-T7 might be responsi-
ble for the cleavage (Geissler et al., 1999). However, the
situation is clearly different from what we have observed
for site no. 4. It has to be kept in mind that all five
processing products described above were also identi-
fied in extracts of infected primary hepatocytes so that
the generation of these proteins cannot be regarded as
mere artifacts (Ko¨nig et al., 1998). Thus, all available data
support the complex processing scheme. The finding
that p41 is cleaved by two different proteases adds a
further level to the scheme. A highly interesting question
for future work is whether the situation is similar for other
caliciviruses. The elucidation of the functional role of
such a complex processing process would at least be
much easier for members of the Vesivirus genus that can
be propagated in tissue culture and are amenable to
genetic manipulation via infectious cDNA clones (Sos-
novtsev and Green, 1995; Thumfart and Meyers, 2002).
MATERIALS AND METHODS
Plasmid construction
Restriction and subcloning were done according to stan-
dard procedures (Sambrook et al., 1989). Nucleotide se-
quencing was done with the Big Dye Terminator Cycle
Sequencing Kit (Perkin–Elmer, Applied Biosystems, Weiter-
stadt, Germany). Analysis of the sequencing products was
done with an ABI Prism 377 DNA Sequencer (Perkin–Elmer
Applied Biosystems). Restriction and modifying enzymes
were purchased from NEB (Schwalbach, Germany), Phar-
macia (Freiburg, Germany), Gibco-BRL (Eggenstein, Ger-
many) and Boehringer Mannheim (Mannheim, Germany).
Plasmid pCITE-2a was purchased from AGS (Heidelberg,
Germany).
A SacI/BglII fragment from the cDNA clone pR1228
(Meyers et al., 2000) was isolated and cloned into
pCITE-2a restricted with the same enzymes resulting in
construct pR890IX. Expression construct pR1303IX was
derived from pR890IX by restriction with XbaI and re-
ligation. The mutants pR1321, 1332a,b, and 1334 a–j were
established in pCITE-2a cut with SacI and XbaI by insert-
ing a SacI/EcoRI fragment containing the desired muta-
tion(s) together with an EcoRI/XbaI fragment derived
from pR1303IX. The fragments with the mutations were
established in pBluescriptSK- (Stratagene, Heidelberg,
Germany) cut with SacI and EcoRI from the PCR frag-
ments with the mutations described below that were cut
with SacI and AflIII and a PCR fragment amplified from
pR1303IX by PCR with primers Ol-P5M2 and M13 reverse
primer cut with EcoRI and AflIII resulting in plasmids
pR1325a–j. The fragments with the mutations were gen-
erated by PCR with pR1303IX as a template and primers
Ol-pCITE and Ol-M201/2R–Ol-M201/11R. PCR was con-
ducted by 35 cycles (30 s 94°C, 30 s 54°C, 60 s 72°C)
with Vent polymerase (NEB) using the buffer and the
conditions proposed by the producer.
Primer sequences in 5 to 3 orientation:
Ol-pCITE: CGGGGACGTGGTTTTCCTTT
Ol-P5M2: TTGACGTGTTCACCGACCCCAACCTCATGT-
CTGGG
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Ol-M201/2R: GAACACGAACGCCGGGGCCACCGCGG-
TGAACGGGGTCTG
Ol-M201/3R: GAACACGTGAACGCCTTGGTCACC
Ol-M201/4R: GAACACGTGAACGCCGGGGTCACC
Ol-M201/5R: GAACACGTCAACGCCGGGGCCACC
Ol-M201/6R: GAACACGTCAACGCCTTGGCCACC
Ol-M201/7R: GAACACGTCAACGCCTTGGTCACCGCG-
GTGAAC
Ol-M201/8R: GAACACGTCAACGCCGGGGTCACCGC-
GGTGAAC
Ol-M201/9R: GAACACGTCAACGCCTTGGTCACCGCG-
GCCAAC
Ol-M201/10R: GAACACGTCAACGCCTTGGTCACCGC-
CGTCAAC
Ol-M201/11R: GAACACGTCAACGCCTTGGTCACCGG-
GGTCAAC
Plasmids pR1303-P2/Cys, pR1303-P1/Cys, and pR1303-
P1/Cys were established from PCR fragments obtained by
amplification of fragments using plasmid pR1325 as a tem-
plate. pR1325 contains the SacI/EcoRI fragment from the
p41 region of pR1228 in pBluescript SK- cut with the same
enzymes. To change the cysteine codon no. 971 residing in
the VPg coding sequence, a fragment “a” was amplified with
oligonucleotides Ol-p5dCys2 andM13 universal primer and
was subsequently cut with NcoI and AflII. The cysteine
codons at positions P2, P1, P1, or P2 of the proposed
cleavage site were introduced by PCR with M13 reverse
primer and oligonucleotides Ol-p5Cys1, Ol-p5Cys2, Ol-
p5Cys3, or Ol-p5Cys4, respectively, and the resulting
fragments “b1,” “b2,” “b3,” or “b4” were cut with AflIII and
SacI. The mutated sequences were established in pR1325
cut with SacI and NcoI by ligation of the plasmid with
fragment a and b1, b2, b3, or b4. The expression constructs
were assembled in pR1303IX as described above for the
other cleavage-site mutants.
Ol-p5dCys2: CTGCCATGGTCGCAAGGTTGACAAGGTG-
GTTTGCCGACAAGTG
Ol-p5Cys1: GAACACGTCAACGCCTTGGTCACAGCGG-
TCAACG
Ol-p5Cys2: GAACACGTCAACGCCTTGGTCACCGCAG-
TCAACG
Ol-p5Cys3: GAACACGTCAACGCCTTGGTCACCGCG-
GCAAACGTTGTC
Ol-p5Cys4: GAACACGTCAACGCCTTGGTCACCGCG-
GTCACAGTTGTCTG
To establish construct pR862 a PCR fragment derived
from pR1228 by amplification with primers Ol-R-Prot-N
and Ol-R-Prot-C was cut with NcoI and EcoRI and in-
serted into pCITE-2a NcoI/EcoRI. Starting with pR862
construct pR1418 was generated by digestion with
Tth111I and BglII and insertion of a Tth111I/BamHI frag-
ment from pR1228.
Primer sequences:
Ol-R-Prot-N: GATCATGCCATGGGTTTTACCTGGGTTC-
ATG
Ol-R-Prot-C: CGGAATTCTATTCATAAACTCCCTTTGTAA
Constructs pR1416a and pR1416b were established in
pCITE-2a by inserting PCR fragments amplified with
primers Ol-pCITE and Ol-CTP41 from pR890II and
pR890IX, respectively. The vector as well as the PCR
fragments were treated with SacI and XbaI before liga-
tion.
Primer sequence:
Ol-CTP41: GACTCTAGATCACTCATAGTCATTGTCATA-
AAAG
The integrity of all PCR fragments was verified by
nucleotide sequencing.
Transient expression, metabolic labeling of proteins,
and immunoprecipitation
For transient expression of plasmids vaccinia virus
MVA-T7 [(Wyatt et al., 1995) kindly provided by B. Moss]
was used. BHK21 cells (5  105 per 3.5-cm dish) (kindly
provided by T. Ru¨menapf, University of Giessen) were
infected with MVA-T7 in 1 ml DMEM lacking FCS at a
multiplicity of infection of 2, incubated at 37°C for 1 h,
washed two times with medium, and transfected with 5
g of the desired plasmid using the Superfect transfec-
tion kit as recommended (Qiagen, Hilden, Germany).
After 3–4 h at 37°C the cells were washed two times with
medium containing no cysteine and no methionine and
incubated in this medium for 1 h. Afterward, the medium
was replaced by labeled medium containing 0.5 mCi/ml
of [35S]methionine/[35S]cysteine (Tran35S-Label, ICN, Es-
chwege, Germany) or, if specified, with [35S]cysteine only.
If not indicated otherwise, the cells were labeled for ca.
16 h at 37°C. Labeling was stopped by removing the
medium, washing the cells with phosphate buffered sa-
line (PBS) two times, and freezing the dishes containing
the dry cells. Cell extracts were prepared under dena-
turing conditions as described before (Ko¨nig et al., 1998).
Extracts were incubated with 5 l of undiluted serum.
Precipitates were formed with cross-linked Staphylococ-
cus aureus (Kessler, 1981) and analyzed by SDS–PAGE
using tricine-buffered gels according to Scha¨gger and
von Jagow (1987). Following electrophoresis, the gels
were fixed for 1 h with an aqueous solution of 30%
methanol and 10% acetic acid, rinsed for 3 h in water
containing 20% methanol and 3% glycerol, vacuum dried
at 60°C, and exposed to BioMax X-ray films (Kodak,
Stuttgart, Germany). The antisera used for detection of
RHDV proteins have been described extensively before
(Wirblich et al., 1996).
For trans-cleavage assays the different plasmids were
mixed at about a molar ratio of 1:1 for the transfection.
The other steps were the same as described above.
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